One-way ANOVA and post-hoc t-tests with Bonferroni correction showed a significant (at the 5% level) difference in the level of TrkB between CNS embryonal tumors (group 3) and ependymal tumors (group 4). This evidence concerns the gene NTRK2 and embryonal neoplasm.